Cargando…

Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival

Since their initial description by Elie Metchnikoff, phagocytes have sparked interest in a variety of biologic disciplines. These important cells perform central functions in tissue repair and immune activation as well as tolerance. Myeloid cells can be immunoinhibitory, particularly in the tumor mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brech, Dorothee, Herbstritt, Anna S., Diederich, Sarah, Straub, Tobias, Kokolakis, Evangelos, Irmler, Martin, Beckers, Johannes, Büttner, Florian A., Schaeffeler, Elke, Winter, Stefan, Schwab, Matthias, Nelson, Peter J., Noessner, Elfriede
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600747/ https://www.ncbi.nlm.nih.gov/pubmed/36291154 http://dx.doi.org/10.3390/cells11203289

Ejemplares similares

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

P31. Genomic profiling and functional characterisation of a new myeloid cell type enriched in renal cell carcinoma
por: Brech, D, et al.
Publicado: (2014)

Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma
por: Büttner, Florian, et al.
Publicado: (2018)

Hypertonicity-Affected Genes Are Differentially Expressed in Clear Cell Renal Cell Carcinoma and Correlate with Cancer-Specific Survival
por: Kandabarau, Siarhei, et al.
Publicado: (2019)

Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG)
por: Lyu, Chen, et al.
Publicado: (2022)

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
por: Fisel, Pascale, et al.
Publicado: (2015)

Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
por: Reustle, Anna, et al.
Publicado: (2022)

Thioredoxin 1 (Trx1) is associated with poor prognosis in clear cell renal cell carcinoma (ccRCC): an example for the crucial role of redox signaling in ccRCC
por: Ribback, Silvia, et al.
Publicado: (2021)

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
por: Geiger, Christiane, et al.
Publicado: (2005)

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

Pharmacogenomics: a key component of personalized therapy
por: Schwab, Matthias, et al.
Publicado: (2012)

DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
por: Noessner, Elfriede
Publicado: (2017)

Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy
por: Fisel, Pascale, et al.
Publicado: (2018)

Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma
por: Sauter-Meyerhoff, Carolin, et al.
Publicado: (2021)

Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer
por: Hänze, Jörg, et al.
Publicado: (2020)

Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
por: Olguín-Contreras, Luis Felipe, et al.
Publicado: (2021)

Reactive astrocytes as neural stem or progenitor cells: In vivo lineage, In vitro potential, and Genome‐wide expression analysis
por: Götz, Magdalena, et al.
Publicado: (2015)

Visualizing allele-specific expression in single cells reveals epigenetic mosaicism in an H19 loss-of-imprinting mutant
por: Ginart, Paul, et al.
Publicado: (2016)

Epigenetic mosaicism and cell burden in Beckwith–Wiedemann syndrome due to loss of methylation at imprinting control region 2
por: Duffy, Kelly A., et al.
Publicado: (2021)

Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach
por: Mancini, Mariangela, et al.
Publicado: (2021)

Variants of PEAR1 Are Associated With Outcome in Patients With ACS and Stable CAD Undergoing PCI
por: Stimpfle, Fabian, et al.
Publicado: (2018)

Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
por: Goldschmied, Andreas, et al.
Publicado: (2023)

Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
por: Winter, Stefan, et al.
Publicado: (2016)

Psammomatoid Calcification-Rich Oncocytic Thyroid Adenoma With Clear-Cell Change
por: Handra-Luca, Adriana, et al.
Publicado: (2019)

Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
por: Nies, Anne T, et al.
Publicado: (2013)

Epithelial cell plasticity drives endoderm formation during gastrulation
por: Scheibner, Katharina, et al.
Publicado: (2021)

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
por: Gürgen, Dennis, et al.
Publicado: (2022)

Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients
por: Bücklein, Veit, et al.
Publicado: (2016)

Tissue-specific and mosaic imprinting defects underlie opposite congenital growth disorders in mice
por: Freschi, Andrea, et al.
Publicado: (2018)

Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
por: Nies, Anne T., et al.
Publicado: (2011)

Unique Lamina Propria Stromal Cells Imprint the Functional Phenotype of Mucosal Dendritic Cells
por: Vicente-Suarez, Ildefonso, et al.
Publicado: (2014)

SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease
por: Rath, Dominik, et al.
Publicado: (2016)

Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018)

Activation of SF(5)CF(3) by the N-Heterocyclic Carbene SIMes
por: Herbstritt, Domenique, et al.
Publicado: (2023)

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
por: Holmen Olofsson, Gitte, et al.
Publicado: (2021)

A Variant of the SLC10A2 Gene Encoding the Apical Sodium-Dependent Bile Acid Transporter Is a Risk Factor for Gallstone Disease
por: Renner, Olga, et al.
Publicado: (2009)

A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort
por: Klein, Kathrin, et al.
Publicado: (2019)

The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center
por: Abdel-Kahaar, Emaad, et al.
Publicado: (2019)

Neonatally imprinted stromal cell subsets induce tolerogenic dendritic cells in mesenteric lymph nodes
por: Pezoldt, Joern, et al.
Publicado: (2018)

Cord Blood Vα24-Vβ11(+) Natural Killer T Cells Display a Th2-Chemokine Receptor Profile and Cytokine Responses
por: Harner, Susanne, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6ar420hmoah0h03d2r8apfooo1